These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33512642)

  • 1. Serum Immunoglobulin G Levels Predict Biochemical and Histological Remission of Autoimmune Hepatitis Type 1: A Single-Center Experience and Literature Review.
    Li Y; Yan L; Wang R; Wang Q; You Z; Li B; Zhang J; Huang B; Chen Y; Li Y; Lian M; Tang R; Qiu D; Gershwin ME; Xiao X; Miao Q; Ma X
    Clin Rev Allergy Immunol; 2022 Apr; 62(2):292-300. PubMed ID: 33512642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.
    Hartl J; Ehlken H; Sebode M; Peiseler M; Krech T; Zenouzi R; von Felden J; Weiler-Normann C; Schramm C; Lohse AW
    J Hepatol; 2018 Apr; 68(4):754-763. PubMed ID: 29180000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
    Dhaliwal HK; Hoeroldt BS; Dube AK; McFarlane E; Underwood JC; Karajeh MA; Gleeson D
    Am J Gastroenterol; 2015 Jul; 110(7):993-9. PubMed ID: 26010310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis.
    Laschtowitz A; Zachou K; Lygoura V; Pape S; Derben F; Jaeckel E; Oller-Moreno S; Weidemann S; Krech T; Piecha F; Schön G; Liebhoff AM; Al Tarrah M; Heneghan M; Drenth JPH; Dalekos G; Taubert R; Lohse AW; Schramm C
    JHEP Rep; 2021 Aug; 3(4):100321. PubMed ID: 34381983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
    Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustained Remission After Treatment Withdrawal in Autoimmune Hepatitis: A Multicenter Retrospective Study.
    Ben Merabet Y; Barbe C; Heurgue-Berlot A; Thévenot T; Minello A; Habersetzer F; Samuel D; Bernard-Chabert B; Weil-Verhoeven D; Renard P; Clot H; Di Martino V; Louvet H; Bresson-Hadni S; Thiéfin G
    Dig Dis Sci; 2021 Jun; 66(6):2107-2117. PubMed ID: 32607807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug withdrawal in patients with autoimmune hepatitis in long-term histological remission: A prospective observational study.
    van den Brand FF; Snijders RJALM; de Boer YS; Verwer BJ; van Nieuwkerk CMJ; Bloemena E; Kuiken SD; Drenth JPH; Bouma G
    Eur J Intern Med; 2021 Aug; 90():30-36. PubMed ID: 33865679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
    Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
    [No Abstract]   [Full Text] [Related]  

  • 9. Features and outcome of AIH patients without elevation of IgG.
    Hartl J; Miquel R; Zachou K; Wong GW; Asghar A; Pape S; Sebode M; Peiseler M; Zenouzi R; Ehlken H; Krech T; Weiler-Normann C; Drenth JPH; Oo YH; Dalekos GN; Heneghan M; Schramm C; Lohse AW
    JHEP Rep; 2020 Jun; 2(3):100094. PubMed ID: 32280942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study.
    Plagiannakos CG; Hirschfield GM; Lytvyak E; Roberts SB; Ismail M; Gulamhusein AF; Selzner N; Qumosani KM; Worobetz L; Hercun J; Vincent C; Flemming JA; Swain MG; Cheung A; Chen T; Grbic D; Peltekain K; Mason AL; Montano-Loza AJ; Hansen BE;
    J Hepatol; 2024 Aug; 81(2):227-237. PubMed ID: 38527524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes.
    Aljumah AA; Al-Ashgar H; Fallatah H; Albenmousa A
    Ann Hepatol; 2019; 18(3):439-444. PubMed ID: 31040094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile autoimmune hepatitis: A comprehensive review.
    Sokollik C; McLin VA; Vergani D; Terziroli Beretta-Piccoli B; Mieli-Vergani G
    J Autoimmun; 2018 Dec; 95():69-76. PubMed ID: 30344030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and histological features of autoantibody-negative autoimmune hepatitis in Chinese patients: a single center experience.
    Wang QX; Jiang WJ; Miao Q; Xiao X; Zhang HY; Huang SS; Shen L; Hua J; Li H; Li S; Qiu DK; Ma X
    J Dig Dis; 2013 Apr; 14(4):175-80. PubMed ID: 23216916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
    Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
    Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of autoimmune hepatitis].
    Chazouillères O
    Gastroenterol Clin Biol; 2009 Oct; 33(10-11 Suppl):F36-43. PubMed ID: 19762185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis.
    Kobayashi M; Kakuda Y; Harada K; Sato Y; Sasaki M; Ikeda H; Terada M; Mukai M; Kaneko S; Nakanuma Y
    World J Gastroenterol; 2014 Apr; 20(13):3597-608. PubMed ID: 24707143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent updates on the management of autoimmune hepatitis.
    Komori A
    Clin Mol Hepatol; 2021 Jan; 27(1):58-69. PubMed ID: 33291862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis.
    Hartl J; Ehlken H; Weiler-Normann C; Sebode M; Kreuels B; Pannicke N; Zenouzi R; Glaubke C; Lohse AW; Schramm C
    J Hepatol; 2015 Mar; 62(3):642-6. PubMed ID: 25457202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis.
    Guedes LR; Cançado GGL; Santos BC; Jacomassi LDS; Nardelli MJ; Osório FMF; Faria LC; Couto CA
    Ann Hepatol; 2024; 29(4):101497. PubMed ID: 38460715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.
    Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G;
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):268-277. PubMed ID: 29050991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.